CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...